Det er forekommet hos tidligere behandlede patienter med mere end 100 eksponeringsdage og med disposition for udvikling af inhibitor.
Cases of recurrent inhibitor (low titre) have been observed after switching from one factor VIII product to another in previously treated patients with more than 100 exposure days who have a history of inhibitor development.